Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127076641 | 12707664 | 1 | I | 20160819 | 20160821 | 20160901 | 20160901 | EXP | BR-ALEXION PHARMACEUTICALS INC-A201606308 | ALEXION | 8.33 | MON | M | Y | 0.00000 | 20160901 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127076641 | 12707664 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 300 MG, UNK, FOR 2 WEEKS | 125166 | 300 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||
| 127076641 | 12707664 | 2 | C | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 127076641 | 12707664 | 3 | C | NIMESULIDE | NIMESULIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 127076641 | 12707664 | 4 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Unknown | 0.4 MG/KG, UNK | 0 | .4 | MG/KG | ||||||||
| 127076641 | 12707664 | 5 | C | NITROPRUSSIDE | NITROPRUSSIDE | 1 | Unknown | 0.3 MCG/KG/MIN | 0 | ||||||||||
| 127076641 | 12707664 | 6 | C | AMOXICILLIN W/CLAVULANIC ACID | AMOXICILLINCLAVULANIC ACID | 1 | Unknown | 0 | |||||||||||
| 127076641 | 12707664 | 7 | C | LINEZOLID. | LINEZOLID | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127076641 | 12707664 | 1 | Haemolytic uraemic syndrome |
| 127076641 | 12707664 | 2 | Pneumonia |
| 127076641 | 12707664 | 3 | Pneumonia |
| 127076641 | 12707664 | 4 | Hypertension |
| 127076641 | 12707664 | 5 | Hypertension |
| 127076641 | 12707664 | 6 | Prophylaxis |
| 127076641 | 12707664 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127076641 | 12707664 | OT |
| 127076641 | 12707664 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127076641 | 12707664 | Abdominal pain | |
| 127076641 | 12707664 | Anuria | |
| 127076641 | 12707664 | Blood creatinine increased | |
| 127076641 | 12707664 | Blood lactate dehydrogenase increased | |
| 127076641 | 12707664 | Diarrhoea | |
| 127076641 | 12707664 | Haemoglobin decreased | |
| 127076641 | 12707664 | Haemolysis | |
| 127076641 | 12707664 | Hyperaemia | |
| 127076641 | 12707664 | Infection | |
| 127076641 | 12707664 | Pancreatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127076641 | 12707664 | 1 | 20160819 | 0 |